BB Biotech (Germany) Market Value
| BBZA Stock | EUR 39.20 0.70 1.82% |
| Symbol | BBZA |
BB Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BB Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BB Biotech.
| 02/27/2024 |
| 11/23/2024 |
If you would invest 0.00 in BB Biotech on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding BB Biotech AG or generate 0.0% return on investment in BB Biotech over 270 days. BB Biotech is related to or competes with CSL, Superior Plus, NMI Holdings, Origin Agritech, SIVERS SEMICONDUCTORS, Talanx AG, and NorAm Drilling. More
BB Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BB Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BB Biotech AG upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 7.94 | |||
| Value At Risk | (2.78) | |||
| Potential Upside | 2.83 |
BB Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BB Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BB Biotech's standard deviation. In reality, there are many statistical measures that can use BB Biotech historical prices to predict the future BB Biotech's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.09) |
BB Biotech AG Backtested Returns
BB Biotech AG retains Efficiency (Sharpe Ratio) of -0.0487, which signifies that the company had a -0.0487% return per unit of price deviation over the last 3 months. BB Biotech exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BB Biotech's Variance of 3.19, information ratio of (0.13), and Market Risk Adjusted Performance of (0.08) to double-check the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 1.21, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BB Biotech will likely underperform. At this point, BB Biotech AG has a negative expected return of -0.087%. Please make sure to confirm BB Biotech's market risk adjusted performance, coefficient of variation, jensen alpha, as well as the relationship between the mean deviation and standard deviation , to decide if BB Biotech AG performance from the past will be repeated sooner or later.
Auto-correlation | 0.79 |
Good predictability
BB Biotech AG has good predictability. Overlapping area represents the amount of predictability between BB Biotech time series from 27th of February 2024 to 11th of July 2024 and 11th of July 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BB Biotech AG price movement. The serial correlation of 0.79 indicates that around 79.0% of current BB Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.7 | |
| Residual Average | 0.0 | |
| Price Variance | 3.97 |
BB Biotech AG lagged returns against current returns
Autocorrelation, which is BB Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BB Biotech's stock expected returns. We can calculate the autocorrelation of BB Biotech returns to help us make a trade decision. For example, suppose you find that BB Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BB Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BB Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BB Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BB Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
BB Biotech Lagged Returns
When evaluating BB Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BB Biotech stock have on its future price. BB Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BB Biotech autocorrelation shows the relationship between BB Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in BB Biotech AG.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in BBZA Stock
BB Biotech financial ratios help investors to determine whether BBZA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BBZA with respect to the benefits of owning BB Biotech security.